REG - Feedback PLC - Medical Imaging Partnership Pilot Agreement

FeedbackAnnouncement

21/02/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240221:nRSU8343Da&default-theme=true

RNS Number : 8343D  Feedback PLC  21 February 2024

 

Feedback plc

 

Feedback opens opportunity in UK private healthcare

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, announces that radiology specialist Medical Imaging
Partnership ("MIP") has agreed to pilot Bleepa-CareLocker, in order to deliver
multiple clinical pathways to its customers in the UK private healthcare
sector.

 

The agreement to pilot, enables both parties to evaluate how a pathway that
enables a 'straight to diagnostic' stage followed by an 'asynchronous MDT'
review, can translate from the NHS model and deliver impact within private
healthcare journeys. The pilot will formally commence on a paid basis after an
initial evaluation and planning period. It is anticipated that Bleepa will
host a number of different diagnostic-led clinical pathways, starting
initially with a novel direct access prostate screening service, pioneered by
MIP, with further pathways across cardiac and Women's Health services to be
onboarded later in the year.

 

Bleepa-CareLocker has been selected by MIP as its preferred digital partner
based on its requirements to view clinical results data securely and remotely,
to conduct asynchronous remote multidisciplinary team ("MDTs") meetings and to
communicate results across provider sites, all through a single platform. It
is anticipated that the pilot will also evaluate the possibility of patient
direct access to results through Feedback's CareLocker application.

 

Patient volumes and associated revenue are expected to be modest in the early
stages, post the evaluation and planning phase, however, management believes
that the importance of this pilot cannot be understated. The fact that this is
a direct translation of the NHS pathway work into the UK private healthcare
sector highlights the important role that the private sector can play in
supporting the NHS recovery and those patients affected by long waiting lists.
It also demonstrates the huge versatility of the Bleepa-CareLocker platform to
deliver care across sectors and is Feedback's first step towards opening a
business line in the UK private sector.

 

Dr Tom Oakley, CEO Feedback plc said: "This exciting programme is the
culmination of years of pathway work alongside UK clinicians. In
Bleepa-CareLocker, we have developed a platform that delivers an unparalleled
value proposition to clinical service partners, both in the NHS and now in the
private sector. This is the first time that we have translated our NHS model
into the private sector and we are excited to see the impact this could have
for private patients and MIP as our clinical service partner and customer. We
hope to use this pilot to open our opportunity in the UK private healthcare
market, which was expected to reach £11 billion in 2023."

 

Steve Bird, CEO of Medical Imaging Partners said: "MIP is developing new
models of diagnostic services in the independent diagnostic sector, including
expanding its range of cancer and cardiac health checks and diagnostic tests.
The company is also delivering a compelling range of direct-to-consumer
diagnostic services that can offer patients choice and fast access at crucial
times in their health and wellness journey. We see Bleepa-CareLocker as the
ideal platform for us to help support these services and we were impressed by
the capabilities and impact delivered in the NHS CDC pilots undertaken
recently and look forward to seeing how this platform can help us to deliver
our own pathways in the independent sector."

 

--Ends--

Enquiries:

 

 Feedback plc                                    +44 (0) 20 3997 7634

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                                Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                            07748 325 236 or 07407 020 470

 

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for
patients. We design products that enhance clinician access to patient data and
to their colleagues. Our unique approach centres around individual patient
episodes, into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available to
clinicians in multiple settings, in a format that enables them to meaningfully
interact with it, providing flexibility to clinicians and free movement of
patients between provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment.

 

Our products Bleepa and CareLocker work together to deliver unparalleled value
to our customers. Bleepa is our application layer and sits on top of
CareLocker as our data layer. Bleepa is a clinician facing platform that
displays clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure, auditable chat
interface that links back to the patient medical record. The CareLocker data
storage model is built around the patient. Our vision is one where relevant
clinical data is always available to the patient as well as to any care
setting that they may attend - a federated data architecture with the patient
as the tenant.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based model is expected to provide increasing levels of
revenue visibility as the Company grows its customer base.

 

About Medical Imaging Partnership

Medical Imaging Partnership has been delivering high-quality radiology and
diagnostic services for both the NHS and the Independent sector for over a
decade. The company has multiple sites and centres across the south of
England, along with diagnostic centres in London, Manchester and Surrey. The
sites provide MRI, CT and Dexa scanning along with Ultrasound services and
other diagnostic services and tests. All locations are led by qualified and
experienced healthcare professionals with a reputation for providing high
quality care and service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRKBLFLZLLXBBV